Daito PharmaceuticalLtd Future Growth
Future criteria checks 3/6
Daito PharmaceuticalLtd is forecast to grow earnings and revenue by 12.3% and 8.4% per annum respectively. EPS is expected to grow by 12.5% per annum. Return on equity is forecast to be 7.7% in 3 years.
Key information
12.3%
Earnings growth rate
12.5%
EPS growth rate
Pharmaceuticals earnings growth | 12.6% |
Revenue growth rate | 8.4% |
Future return on equity | 7.7% |
Analyst coverage | Low |
Last updated | 14 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
5/31/2026 | 56,150 | 4,415 | 5,920 | N/A | 2 |
5/31/2025 | 52,150 | 3,925 | 5,200 | N/A | 2 |
5/31/2024 | 47,600 | 3,340 | -1,183 | N/A | 2 |
2/29/2024 | 45,193 | 3,279 | N/A | N/A | N/A |
11/30/2023 | 45,844 | 3,390 | -2,689 | 4,960 | N/A |
8/31/2023 | 45,238 | 3,337 | N/A | N/A | N/A |
5/31/2023 | 45,101 | 3,600 | -1,401 | 4,155 | N/A |
2/28/2023 | 44,451 | 3,350 | N/A | N/A | N/A |
11/30/2022 | 44,368 | 3,653 | -1,619 | 3,104 | N/A |
8/31/2022 | 43,759 | 3,789 | N/A | N/A | N/A |
5/31/2022 | 43,464 | 4,668 | -363 | 4,370 | N/A |
2/28/2022 | 44,462 | 4,525 | N/A | N/A | N/A |
11/30/2021 | 45,142 | 4,600 | 221 | 5,870 | N/A |
8/31/2021 | 46,757 | 4,750 | N/A | N/A | N/A |
5/31/2021 | 48,714 | 4,246 | -1,167 | 5,182 | N/A |
2/28/2021 | 48,454 | 4,402 | N/A | N/A | N/A |
11/30/2020 | 47,773 | 4,365 | -543 | 3,455 | N/A |
8/31/2020 | 47,036 | 4,345 | N/A | N/A | N/A |
5/31/2020 | 44,991 | 3,944 | 1,533 | 4,306 | N/A |
2/29/2020 | 45,105 | 4,204 | N/A | N/A | N/A |
11/30/2019 | 44,242 | 3,842 | 4,520 | 7,481 | N/A |
8/31/2019 | 43,053 | 3,654 | N/A | N/A | N/A |
5/31/2019 | 41,134 | 3,513 | 3,226 | 6,888 | N/A |
2/28/2019 | 40,640 | 3,291 | N/A | N/A | N/A |
11/30/2018 | 39,566 | 3,127 | 2,215 | 5,829 | N/A |
8/31/2018 | 39,933 | 3,147 | N/A | N/A | N/A |
5/31/2018 | 39,875 | 3,041 | 1,593 | 5,465 | N/A |
2/28/2018 | 39,701 | 2,913 | N/A | N/A | N/A |
11/30/2017 | 39,219 | 2,820 | N/A | 4,539 | N/A |
8/31/2017 | 38,554 | 2,658 | N/A | N/A | N/A |
5/31/2017 | 37,984 | 2,656 | N/A | 5,069 | N/A |
2/28/2017 | 37,283 | 2,698 | N/A | N/A | N/A |
11/30/2016 | 37,270 | 2,722 | N/A | 3,385 | N/A |
8/31/2016 | 36,747 | 2,559 | N/A | N/A | N/A |
5/31/2016 | 36,370 | 2,566 | N/A | 2,948 | N/A |
2/29/2016 | 36,416 | 2,639 | N/A | N/A | N/A |
11/30/2015 | 35,691 | 2,403 | N/A | 3,252 | N/A |
8/31/2015 | 35,370 | 2,468 | N/A | N/A | N/A |
5/31/2015 | 34,058 | 2,246 | N/A | 3,739 | N/A |
2/28/2015 | 33,765 | 2,080 | N/A | N/A | N/A |
11/30/2014 | 32,528 | 2,010 | N/A | 3,709 | N/A |
8/31/2014 | 31,560 | 1,864 | N/A | N/A | N/A |
5/31/2014 | 31,196 | 1,811 | N/A | 2,744 | N/A |
2/28/2014 | 29,876 | 1,910 | N/A | N/A | N/A |
11/30/2013 | 29,680 | 1,787 | N/A | 2,990 | N/A |
8/31/2013 | 29,050 | 1,799 | N/A | N/A | N/A |
5/31/2013 | 28,956 | 1,786 | N/A | 2,541 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4577's forecast earnings growth (12.3% per year) is above the savings rate (0.2%).
Earnings vs Market: 4577's earnings (12.3% per year) are forecast to grow faster than the JP market (9.4% per year).
High Growth Earnings: 4577's earnings are forecast to grow, but not significantly.
Revenue vs Market: 4577's revenue (8.4% per year) is forecast to grow faster than the JP market (4.4% per year).
High Growth Revenue: 4577's revenue (8.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4577's Return on Equity is forecast to be low in 3 years time (7.7%).